-
EP3845652
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3845652
| EP3845652 - ANTIBODY INDUCING IMMUNE TOLERANCE, INDUCED LYMPHOCYTE, AND CELL THERAPY AGENT THERAPEUTIC METHOD USING INDUCED LYMPHOCYTE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.06.2021 Database last updated on 12.07.2024 | |
| Former | The international publication has been made Status updated on 27.12.2019 | Most recent event Tooltip | 13.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states JUNTEN BIO Co., Ltd. 1-3, Nihonbashi 2-chome Chuo-ku Tokyo 103-0027 / JP | [2021/27] | Inventor(s) | 01 /
MAEDA, Ryu c/o Gene Techno Science Co., Ltd., Kanayama Bldg. 3FI 1-2-12 Arakawa Chuo-ku, Tokyo 1040033 / JP | 02 /
KAWAKAMI, Masayuki c/o Gene Techno Science Co., Ltd., Kanayama Bldg. 3FI 1-2-12 Arakawa Chuo-ku, Tokyo 1040033 / JP | 03 /
UCHIDA, Koichiro c/o Juntendo University, 2-1-1, Hongo, Bunkyo-ku Tokyo 113-8421 / JP | 04 /
TAKEDA, Kazuyoshi c/o Juntendo University, 2-1-1, Hongo, Bunkyo-ku Tokyo 113-8421 / JP | 05 /
OKUMURA, Ko c/o Juntendo University, 2-1-1, Hongo, Bunkyo-ku Tokyo 113-8421 / JP | [2021/27] | Representative(s) | Engelhard, Markus Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [2021/27] | Application number, filing date | 19823720.8 | 21.06.2019 | [2021/27] | WO2019JP24752 | Priority number, date | JP20180118996 | 22.06.2018 Original published format: JP 2018118996 | [2021/27] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019245037 | Date: | 26.12.2019 | Language: | JA | [2019/52] | Type: | A1 Application with search report | No.: | EP3845652 | Date: | 07.07.2021 | Language: | EN | [2021/27] | Search report(s) | International search report - published on: | JP | 26.12.2019 | (Supplementary) European search report - dispatched on: | EP | 14.03.2022 | Classification | IPC: | C12N15/62, A61K39/395, A61P37/02, A61P37/06, A61P37/08, C07K16/28, C07K16/46, C12N1/15, C12N1/19, C12N1/21, C12N5/078, C12N5/10, C12N15/13, C12N15/63, C12P21/08 | [2021/27] | CPC: |
C07K16/2827 (EP,KR,US);
A61K39/395 (IL);
A61K35/17 (US);
A61K39/4611 (EP,IL,KR);
A61K39/4621 (EP,IL,KR);
A61K39/46434 (EP,IL,KR);
A61P37/02 (EP,IL);
A61P37/06 (EP,IL,KR,US);
A61P37/08 (EP,IL);
C07K16/28 (IL);
C07K16/2818 (KR);
C07K16/46 (IL);
C12N15/62 (IL);
C12N15/63 (IL);
C12N5/0636 (EP,IL,KR,US);
C12N5/10 (IL);
A61K2039/505 (KR,US);
C07K2317/24 (EP,KR,US);
C07K2317/31 (KR);
C07K2317/52 (US);
C07K2317/565 (KR,US);
C07K2317/70 (EP);
C07K2317/73 (EP);
C07K2317/76 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/27] | Title | German: | ANTIKÖRPER ZUR INDUZIERUNG VON IMMUNTOLERANZ, INDUZIERTER LYMPHOZYT UND THERAPEUTISCHES VERFAHREN MIT ZELLTHERAPIEMITTEL MIT VERWENDUNG VON INDUZIERTEM LYMPHOZYT | [2021/27] | English: | ANTIBODY INDUCING IMMUNE TOLERANCE, INDUCED LYMPHOCYTE, AND CELL THERAPY AGENT THERAPEUTIC METHOD USING INDUCED LYMPHOCYTE | [2021/27] | French: | ANTICORPS INDUISANT LA TOLÉRANCE IMMUNITAIRE, LYMPHOCYTE INDUIT, ET PROCÉDÉ THÉRAPEUTIQUE D'AGENT DE THÉRAPIE CELLULAIRE UTILISANT UN LYMPHOCYTE INDUIT | [2021/27] | Entry into regional phase | 19.01.2021 | Translation filed | 19.01.2021 | National basic fee paid | 19.01.2021 | Search fee paid | 19.01.2021 | Designation fee(s) paid | 19.01.2021 | Examination fee paid | Examination procedure | 19.01.2021 | Examination requested [2021/27] | 28.09.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 14.06.2021 | Renewal fee patent year 03 | 28.06.2022 | Renewal fee patent year 04 | 12.05.2023 | Renewal fee patent year 05 | 13.05.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0189567 (IDEC PHARMA CORP [US], et al) [Y] 1-15 * (page 1, lines 6-21; page 19, line 22-page 20, line 5, Examples);; claims 1-28 *; | [Y]WO2004076488 (THERAVISION GMBH [DE], et al) [Y] 1-15* page 10, 2nd paragraph to page 11, paragraph 5;; claims 1-10 *; | [Y]WO2014186193 (ABWIZ BIO INC [US]) [Y] 1-15 * [0030]-[0036];; claims 1-22 * | International search | [XY]JP2016520081 [X] 1-4, 8-18, 21, 23-41 * , * [Y] 1-41; | [XY] - Vesna Blazevic; Mac Trubey C; Gene M Shearer, "Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses", Journal of clinical immunology, (20010701), vol. 21, no. 4, ISSN 0271-9142, pages 293 - 302, XP019281034 [X] 1-4, 8-18, 21, 23-25 * , Abstract, p. 294 2 4A, 4B * [Y] 1-41 | [XY] - Atsushi Inoue, Chang-Sung Koh, Masashi Yamazaki and Hideo Yagita, "Effect of anti-B7-1 and anti-B7-2 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease", The Journal of Immunology, (19991201), vol. 163, no. 11, ISSN 0022-1767, pages 6180 - 6186, XP055665712 [X] 1-4, 8-18, 21, 23-25 * , Abstract, p. 6181 2 p. 6184 1 Fig. 5A, 5B * [Y] 1-41 | [A] - Anonymous, "CD 80 (B7-1) Mouse anti-Human, Functional Grade, Clone: 2D10.4, eBioscience", (20190821), pages 1 - 2, Fisher scientific, URL: https://www.fishersci.se/shop/products/cd80-b7-1-mouse-anti-human-clone-2d10-4-functional-grade-ebioscience/15218517, XP055665721 [A] 1-41 * , * | [A] - Anonymous, "CD 86 (B7-2) Mouse anti-Human, Functional Grade, Clone: IT 2.2, eBioscience", (20190821), pages 1 - 2, Fisher scientific, URL: https://www.fishersci.se/shop/products/cd86-b7-2-mouse-anti-human-clone-it2-2-functional-grade-ebioscience/15218527, XP055665719 [A] 1-41 | [A] - Watanabe M; Kumagai-Braesch Makiko; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson S Lind; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon B-G, "Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells A Comparison Study of Anti- CD 80/86 mAbs and CTLA4-lg Costimulatory Blockade", Cell Transplantation, (20180927), vol. 27, no. 11, doi::10.1177/0963689718794642, ISSN 0963-6897, pages 1692 - 1704, XP055665723 [A] 1-41 * , * DOI: http://dx.doi.org/10.1177/0963689718794642 | by applicant | EP0125023 | US4816567 | WO9103493 | EP0546073 | US5585089 | JP2002504120 | JP2007131598 | JP2018118996 | JP2018119001 | JP2018190031 | - SATORU TODO et al., Hepatorogy, (20160000), vol. 2, no. 64, pages 632 - 643 | - TERAOKA SKOYAMA IBASHUDA HUCHIDA KTONSHO M et al., J Transplant Res, (20170000), vol. 2, no. 1, pages 1 - 8 | - BASHUDA H et al., J. Clin. Invest., (20050000), vol. 115, pages 1896 - 1902 | - YODOSHA, Protein experiment handbook, (20030000), pages 92 - 96 | - KOHLER GMILSTEIN C., Nature, (19750807), vol. 256, no. 5517, pages 495 - 497 | - CLACKSON et al., Nature, (19910815), vol. 352, no. 6336, pages 624 - 628 | - MARKS et al., J Mol Biol, (19911205), vol. 222, no. 3, pages 581 - 597 | - ROGUSKA et al., Proc Natl Acad Sci USA, (19940201), vol. 91, no. 3, pages 969 - 973 | - ALMAGRO et al., Front Biosci, (20080101), vol. 13, pages 1619 - 1633 | - OZAKI et al., Blood, (19990601), vol. 93, no. 11, pages 3922 - 3930 | - ROGUSKA et al., Proc Natl Acad Sci U S A, (19940201), vol. 91, no. 3, pages 969 - 973 | - DAMSCHRODER et al., Mol Immunol, (20070122), vol. 44, no. 11, pages 3049 - 3060 | - RIECHMANN et al., Nature, (19880324), vol. 332, no. 6162, pages 323 - 327 | - LONBERG et al., Int Rev Immunol, (19950000), vol. 13, no. 1, pages 65 - 93 | - VAUGHAN et al., Nat Biotechnol, (19960300), vol. 14, no. 3, pages 309 - 314 | - CHOTHIALESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917 | - GALFRE, GMILSTEIN, C, Methods Enzymol., (19810000), vol. 73, pages 3 - 46 | - Nature, (19750000), vol. 256, page 495 | - Eur. J. Immunol., (19760000), vol. 6, page 292 | - Curr. Top. Microbiol. Immunol., (19780000), vol. 81, page 1 | - J. Immunol., (19790000), vol. 123, page 1548 | - Nature, (19780000), vol. 276, page 269 | - J. Immunol. Methods, (19800000), vol. 35, page 1 | - TOMIZUKA et al., Nature Genet., (19970000), vol. 15, pages 146 - 156 | - MORRISON, S. L. et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855 | - L. RIEOHMANN et al., Nature, (19880000), vol. 332, page 323 | - KETTLEBOROUGH, C.A. et al., Protein Eng., (19910000), vol. 4, pages 773 - 783 | - CLARK M., Immunol. Today., (20000000), vol. 21, pages 397 - 402 | - MINISTRY OF THE ENVIRONMENT NOTIFICATION, "Act on Welfare and Management of Animals", Guideline for Raising and Keeping of Laboratory Animals, (20060000), no. 88 | - MINISTRY OF EDUCATION, CULTURE, SPORTS, SCIENCE AND TECHNOLOGY, Fundamental guidelines for proper conduct of animal experiment and related activities in Academic research institutions, (20060000), no. 71 |